InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 17.88
+0.02 (0.11%)
Jul 17, 2025, 11:59 AM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 35.50 billion as of July 16, 2025. Its market cap has increased by 298.28% in one year.
Market Cap
35.50B
Enterprise Value
29.66B
Revenue
1.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.88
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 35.50B, an increase of 189.11%. That is a compound annual growth rate of 22.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 34.96B | 176.72% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 232.74B |
| Hansoh Pharmaceutical Group Company | 187.29B |
| Innovent Biologics | 140.17B |
| JD Health International | 136.32B |
| WuXi Biologics | 108.85B |
| Sino Biopharmaceutical | 106.06B |
| Akeso | 101.61B |
| CSPC Pharmaceutical Group | 90.75B |